TGFB1 and pulmonary fibrosis: To best of our knowledge, it is the first study documenting that NAC treatment ameliorates bleomycin-induced pulmonary fibrosis by increasing the MMP-9/TIMP ratio and decreasing the production of TGF-β1 in rats.